Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Kavallaris

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 26, 2006
Acid-cleavable polymeric core-shell particles for delivery of hydrophobic drugsYannie Chan, Volga Bulmus, M Hadi Zareie, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Targeting Functional Activity of AKT Has Efficacy against Aggressive NeuroblastomaMarion Le Grand, Kathleen Kimpton, Christine C Gana, et al.
Biomaterials Science|July 29, 2015
The endocytic pathway and therapeutic efficiency of doxorubicin conjugated cholesterol-derived polymersSema Sevimli, Sharon Sagnella, Alexander Macmillan, et al.
Genome Research|June 27, 2022
High temporal resolution RNA-seq time course data reveals widespread synchronous activation between mammalian lncRNAs and neighboring protein-coding genesWalter Muskovic, Eve Slavich, Ben Maslen, et al.
Chemical Science|June 24, 2021
Monitoring the heterogeneity in single cell responses to drugs using electrochemical impedance and electrochemical noiseYing Yang, Friederike M Mansfeld, Maria Kavallaris, et al.
Theranostics|July 14, 2022
Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapyDannielle H Upton, Caitlin Ung, Sandra M George, et al.
Molecular Cancer Therapeutics|May 6, 2010
Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulinPei Pei Gan, Joshua A McCarroll, Sela T Po'uha, et al.
Chemical Society Reviews|August 8, 2022
How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells?Vu Thanh Cong, Jacinta L Houng, Maria Kavallaris, et al.
Journal of Drug Targeting|January 18, 2014
Magnetic catechin-dextran conjugate as targeted therapeutic for pancreatic tumour cellsOrazio Vittorio, Valerio Voliani, Paolo Faraci, et al.
Theranostics|June 3, 2020
Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivationMarion Le Grand, Anna Mukha, Jakob Püschel, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 26, 2006
Acid-cleavable polymeric core-shell particles for delivery of hydrophobic drugsYannie Chan, Volga Bulmus, M Hadi Zareie, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Targeting Functional Activity of AKT Has Efficacy against Aggressive NeuroblastomaMarion Le Grand, Kathleen Kimpton, Christine C Gana, et al.
Biomaterials Science|July 29, 2015
The endocytic pathway and therapeutic efficiency of doxorubicin conjugated cholesterol-derived polymersSema Sevimli, Sharon Sagnella, Alexander Macmillan, et al.
Genome Research|June 27, 2022
High temporal resolution RNA-seq time course data reveals widespread synchronous activation between mammalian lncRNAs and neighboring protein-coding genesWalter Muskovic, Eve Slavich, Ben Maslen, et al.
Chemical Science|June 24, 2021
Monitoring the heterogeneity in single cell responses to drugs using electrochemical impedance and electrochemical noiseYing Yang, Friederike M Mansfeld, Maria Kavallaris, et al.
Theranostics|July 14, 2022
Challenges and opportunities to penetrate the blood-brain barrier for brain cancer therapyDannielle H Upton, Caitlin Ung, Sandra M George, et al.
Molecular Cancer Therapeutics|May 6, 2010
Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulinPei Pei Gan, Joshua A McCarroll, Sela T Po'uha, et al.
Chemical Society Reviews|August 8, 2022
How can we use the endocytosis pathways to design nanoparticle drug-delivery vehicles to target cancer cells over healthy cells?Vu Thanh Cong, Jacinta L Houng, Maria Kavallaris, et al.
Journal of Drug Targeting|January 18, 2014
Magnetic catechin-dextran conjugate as targeted therapeutic for pancreatic tumour cellsOrazio Vittorio, Valerio Voliani, Paolo Faraci, et al.
Theranostics|June 3, 2020
Interplay between MycN and c-Myc regulates radioresistance and cancer stem cell phenotype in neuroblastoma upon glutamine deprivationMarion Le Grand, Anna Mukha, Jakob Püschel, et al.
Pageof 16